# MRFAP1

## Overview
MRFAP1 (Morf4 family associated protein 1) is a gene that encodes a nuclear protein involved in critical cellular processes, particularly within the NEDD8-Cullin E3 ligase pathway. This protein is primarily associated with chromatin modification, playing a significant role in the acetylation of histone H4, which is essential for regulating chromatin activity and gene expression (Larance2012Characterization). MRFAP1 is expressed in specific cell types, including spermatogonia, ciliated epithelial cells, and neurons, and is notably involved in spermatogenesis and early meiosis (Larance2012Characterization). The protein interacts with various partners, such as MORF4L1, influencing chromatin-modifying enzyme complexes and potentially regulating pathways that maintain germ stem cell populations (Larance2012Characterization). MRFAP1's involvement in protein homeostasis and its regulatory interactions make it a protein of interest in cancer research, with implications for therapeutic strategies in gastric, cervical, and prostate cancers (Shadeo2008Up; Almeida2022CRISPRCas9; Jariwala2007Identification).

## Function
MRFAP1 (Morf4 family associated protein 1) is a protein involved in several critical cellular processes, particularly within the context of the NEDD8-Cullin E3 ligase pathway. This pathway is essential for protein homeostasis, influencing the degradation of cell cycle regulators and transcriptional control networks (Larance2012Characterization). MRFAP1 is primarily active in the nucleus, where it plays a role in chromatin modification, specifically in the acetylation of histone H4, which is crucial for regulating chromatin activity (Larance2012Characterization).

The protein is expressed in a limited number of cell types, including spermatogonia, ciliated epithelial cells, and neurons, with a notable role in spermatogenesis and the initial stages of meiosis (Larance2012Characterization). MRFAP1 interacts with MORF4L1, and this interaction is significant for chromatin modification processes. It regulates the binding of MORF4L1 to chromatin-modifying enzymes, potentially inhibiting the MORF4L1-MRGBP modification complex, which may block the hyperacetylation pathway and maintain a germ stem cell population (Larance2012Characterization).

MRFAP1 is characterized by a fast turnover rate and is degraded via the ubiquitin-proteasome system. Its stability increases upon inhibition of the NEDD8 pathway, suggesting a regulatory mechanism involving ubiquitin-mediated degradation (Larance2012Characterization).

## Clinical Significance
MRFAP1 has been implicated in various cancers due to its role in gene expression regulation and chromatin remodeling. In gastric cancer, knockout studies using CRISPR/Cas9 technology have shown that the absence of MRFAP1 leads to decreased cell vitality, increased cell cycle arrest, and apoptosis, suggesting its involvement in tumor progression. Targeting MRFAP1 interactions may improve therapeutic outcomes in gastric cancer (Almeida2022CRISPRCas9).

In cervical intraepithelial neoplasia (CIN), MRFAP1 expression is significantly increased in CIN III compared to normal cervical tissue. This upregulation is associated with processes characteristic of epithelial cancers, such as proliferation and transcriptional regulation, indicating a potential role in cervical cancer progression (Shadeo2008Up).

MRFAP1 is also involved in the NEDD8-Cullin E3 ligase pathway, which is crucial for protein homeostasis. Alterations in MRFAP1 expression or interactions, particularly with MORF4L1, may impact chromatin modification and protein degradation pathways, potentially influencing cancer therapy outcomes (Larance2012Characterization).

In prostate cancer, MRFAP1 is regulated by the androgen receptor (AR) and shows complex expression patterns in response to androgen signaling, suggesting its involvement in AR-mediated pathways in prostate cancer (Jariwala2007Identification).

## Interactions
MRFAP1 (Morf4 family associated protein 1) is involved in several protein-protein interactions, particularly within the context of the NEDD8-Cullin E3 ligase pathway. It interacts with E3 ubiquitin ligases such as CUL4B, UBR5 (EDD), and HUWE1, as well as with Cullin-4A/B and its substrate-binding protein VprBP. The deubiquitination enzyme OTUB1 is also identified as an interactor (Larance2012Characterization). MRFAP1 forms a complex with MORF4L1, and this interaction is mutually exclusive with MRGBP, a component of the NuA4 histone acetyltransferase complex. This suggests that MRFAP1 may regulate MORF4L1's interaction with chromatin-modifying enzymes by competing with MRGBP for binding (Lamond2012Advancing; Larance2012Characterization).

MRFAP1 is also involved in the regulation of chromatin structure and gene expression, potentially by preventing MORF4L1 from recruiting the NuA4 complex to chromatin (Larance2012Characterization). In gastric cancer cells, MRFAP1 interacts with the cell cycle-related protein P27, particularly in the presence of the neddylation inhibitor MLN4924, which stabilizes this interaction (hu2018mrfap1). MRFAP1 is ubiquitinated and degraded by the CUL7/Fbxw8 E3 ligase complex, highlighting its role in cell cycle regulation (Shi2020The).


## References


[1. (Shi2020The) Le Shi, Dongyue Du, Yunhua Peng, Jiankang Liu, and Jiangang Long. The functional analysis of cullin 7 e3 ubiquitin ligases in cancer. Oncogenesis, October 2020. URL: http://dx.doi.org/10.1038/s41389-020-00276-w, doi:10.1038/s41389-020-00276-w. This article has 14 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41389-020-00276-w)

[2. (Lamond2012Advancing) Angus I. Lamond, Mathias Uhlen, Stevan Horning, Alexander Makarov, Carol V. Robinson, Luis Serrano, F. Ulrich Hartl, Wolfgang Baumeister, Anne Katrin Werenskiold, Jens S. Andersen, Ole Vorm, Michal Linial, Ruedi Aebersold, and Matthias Mann. Advancing cell biology through proteomics in space and time (prospects). Molecular &amp; Cellular Proteomics, 11(3):O112.017731, March 2012. URL: http://dx.doi.org/10.1074/mcp.O112.017731, doi:10.1074/mcp.o112.017731. This article has 80 citations.](https://doi.org/10.1074/mcp.O112.017731)

[3. (Larance2012Characterization) Mark Larance, Kathryn J. Kirkwood, Dimitris P. Xirodimas, Emma Lundberg, Mathias Uhlen, and Angus I. Lamond. Characterization of mrfap1 turnover and interactions downstream of the nedd8 pathway. Molecular &amp; Cellular Proteomics, 11(3):M111.014407, March 2012. URL: http://dx.doi.org/10.1074/mcp.M111.014407, doi:10.1074/mcp.m111.014407. This article has 31 citations.](https://doi.org/10.1074/mcp.M111.014407)

[4. (Shadeo2008Up) Ashleen Shadeo, Raj Chari, Kim M Lonergan, Andrea Pusic, Dianne Miller, Tom Ehlen, Dirk Van Niekerk, Jasenka Matisic, Rebecca Richards-Kortum, Michele Follen, Martial Guillaud, Wan L Lam, and Calum MacAulay. Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia. BMC Genomics, 9(1):64, 2008. URL: http://dx.doi.org/10.1186/1471-2164-9-64, doi:10.1186/1471-2164-9-64. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2164-9-64)

[5. (Jariwala2007Identification) Unnati Jariwala, Jennifer Prescott, Li Jia, Artem Barski, Steve Pregizer, Jon P Cogan, Armin Arasheben, Wayne D Tilley, Howard I Scher, William L Gerald, Grant Buchanan, Gerhard A Coetzee, and Baruch Frenkel. Identification of novel androgen receptor target genes in prostate cancer. Molecular Cancer, June 2007. URL: http://dx.doi.org/10.1186/1476-4598-6-39, doi:10.1186/1476-4598-6-39. This article has 79 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-6-39)

6. (hu2018mrfap1) L Hu, N BAI, Z-G BAI, X-M MA, and Z-T Zhang. Mrfap1 plays a protective role in neddylation inhibitor mln4924-mediated gastric cancer cell death. European Review for Medical & Pharmacological Sciences, 2018. This article has 7 citations.

[7. (Almeida2022CRISPRCas9) Renata Sanches Almeida, Fernanda Wisnieski, Bruno Takao Real Karia, and Marilia Arruda Cardoso Smith. Crispr/cas9 genome-editing technology and potential clinical application in gastric cancer. Genes, 13(11):2029, November 2022. URL: http://dx.doi.org/10.3390/genes13112029, doi:10.3390/genes13112029. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes13112029)